Serum Institute of India: Novavax’s COVID-19 vaccine “Covovax” production begins
The first batch of Novavax’s COVID-19 vaccine “Covovax” production has begun in Serum Institute of India at Pune, announced by…
The first batch of Novavax’s COVID-19 vaccine “Covovax” production has begun in Serum Institute of India at Pune, announced by…
SII is yet to receive raw materials from the US needed to supply the Novavax vaccine.
In September 2020, Novavax announced a manufactured agreement with Serum Institute of India for its COVID-19 vaccine candidate NVX-CoV2373.